Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: A meta-analysis

Digestion

Volumn 59, Issue SUPPL. 2, 1998, Pages 54-57

  Bernard, Brigite ^a   Grangé, Jean Didier ^b   Khac, Eric Nguyen ^a   Amiot, Xavier ^b   Opolon, Pierre ^a   Poynard, Thierry ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL TENON   (France)

Author keywords

Antibiotic prophylaxis; Cirrhosis; Infection

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ASCITES; BACTERIAL INFECTION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; ESCHERICHIA COLI; HUMAN; LIVER CIRRHOSIS; META ANALYSIS; PRIORITY JOURNAL; PSEUDOMONAS; SURVIVAL;

EID: 0031853718     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051423     Document Type: Conference Paper

References (14)

1. Runion BA: Spontaneous bacterial peritonitis: An explosion of information. Hepatology 1988; 8:171-175.
2. Soriano G, Guarner C, Teixido M, Such J, Barrios J, Enriquez J, Vilardell F: Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 1991;100: 477-481.
3. Toledo C, Salmerón JM, Rimola A, Toledo C, Salmerón JM, Rimola A, Navasa M, Arroyo V, Llach J, Ginès A, Ginès L, Rodés J: Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993;17:251-257.
4. Hoefs JC: Spontaneous bacterial peritonitis: Prevention and therapy. Hepatology 1990;12: 776-781.
5. Titó L, Rimola A, Ginès P, Llach J, Arroyo V, Rodés J: Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors. Hepatology 1988;8:27-31.
6. Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West B: Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995;108:1835-1841.
7. Ginès P, Rimola A, Planas R, Vargas V, Marco F, Almela M, Forné M, Miranda ML, Llach J, Salmeron JM, Esteve M, Marqués JM, Jimenez de Anta MT, Arroyo V, Rodés J: Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind placebo-controlled trial. Hepatology 1990;12: 716-724.
8. Rolachon A, Cordier L, Bacq Y, Nousbaum JB, Franza A, Paris JC, Fratte S, Bohn B, Kitmacher L, Stahl JP, Zarski JP: Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: Results of a prospective controlled trial. Hepatology 1995;22:1171-1174.
9. Singh N, Gayowski T, Yu VL, Wagener MM: Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: A randomized trial. Ann Intern Med 1995;122:595-598.
10. Grange JD, Roulot D, Pelletier G, Pariente EA, Denis J, Ink O, Blanc P, Richardet JP, Vinel JP, Delisle F, Fisher D, Flahault A, Amiót X: Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: A double-blind randomized trial. Gastroenterology 1994;106:A901.
11. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC: Meta-analyses of randomized controlled trials. N Engl J Med 1987;316: 450-155.
12. Yusuf S, Peto R, Lewis J, Collins R, Sleight P: Beta-blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-371.
13. Der Simonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
14. Inadomi J, Sonnenberg A: Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis. Gastroenterology 1997;113:1289-1294.